36
Participants
Start Date
July 31, 2013
Primary Completion Date
September 5, 2017
Study Completion Date
May 23, 2019
botulinum toxin type A
"Experimental arm group:~* 150 Units in rectus femoris ( 3 ml and 3 points)~* 70 units in medial gastrocnemius (1.4 ml and 1 point)~* 70 units in lateral gastrocnemius ( 1.4 ml and 1 point)~* 60 units in soleus ( 1.2 ml and 3 points)"
injection of NaCl 0.9%
"Placebo comparator group: injection of NaCl 0.9%:~* 3 ml of NaCl 0.9% in rectus femoris in 3 points~* 1.4 ml of NaCl 0.9% in medial gastrocnemius in 1 point~* 1.4 ml of Nacl 0.9% in lateral gastrocnemius in 1 point~* 1.2 ml of NaCl 0.9% in soleus in 3 points"
Service de médecine physique et réadaptation CHU de Brest, Brest
Centre de rééducation de l'ADAPT Montargis, Amilly
Nicolas Roche, Garches
Collaborators (1)
Allergan
INDUSTRY
Assistance Publique - Hôpitaux de Paris
OTHER